Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (288)
- COVID-19 (164)
- Safety monitoring and information (112)
- Compliance and enforcement (85)
- Legislation (77)
- Manufacturing (59)
- Vaping hub (56)
- Labelling and packaging (41)
- Import and export (35)
- Medicinal cannabis hub (27)
- Scheduling (national classification system) (27)
- Sunscreens (20)
- Weight loss products (18)
- Shortages and supply disruptions (11)
- Committees and advisory bodies (9)
- Cosmetics (6)
- Unique Device Identification (UDI) hub (5)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1273 result(s) found, displaying 1076 to 1100
-
BlogContamination has been discovered in some ranitidine products, but the immediate health risk is low.
-
BlogConsumer Medicine Information gives you the information you need to manage your health
-
Media releasesThe TGA has released the findings of its review into breast implants and breast tissue expanders
-
BlogFun facts about pirate medicine for Talk Like A Pirate Day
-
Media releasesInternational Collaborative Review Initiative gives provisional approval of lenvatinib in combination with pembrolizumab
-
News articlesCommonly asked questions about stem cells and regulation
-
Media releasesInfringement notice issued for the alleged advertising of a cancelled therapeutic good
-
Media releasesInfringement notice issued for the alleged advertising of Schedule 4 substances
-
Regulatory decision noticesNew requirements for caffeine and caffeine-containing ingredients within listed medicines
-
Regulatory decision noticesAn amendment to the Therapeutic Goods (Permissible Ingredients) Determination commenced on 2 September 2019.
-
BlogWhen a company makes a medicine, quality is planned for with Good Manufacturing Practice.
-
Safety updatesMedicines Safety Update article
-
Media releasesUpdate on amendments to the Therapeutic Goods Advertising Code (No.2) 2018 and medicines advertising pre-approval
-
Media releasesThe TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices
-
News articlesRecommended paracetamol doses and labelling requirements.
-
Regulatory decision noticesDirection Notice issued to cease advertising of therapeutic goods not entered in the ARTG
-
Regulatory decision noticesDirection Notice issued to cease advertising of unregistered therapeutic goods to consumers
-
News articlesThe TGA will not pursue the development of an alternative quality standard for sunscreen excipient ingredients at this time in 2019.
-
Safety updatesSafety information: regulators review balloon and stent devices used to unblock blood vessels in the legs
-
Media releasesAn individual has been fined for the alleged importation of unapproved cosmetic products after returning from an overseas trip to China
-
Media releasesInfringement notices issued for the alleged importation and advertising of unapproved performance and image enhancing products
-
News articlesInformation for consumers on the use of performance and image enhancing drugs
-
Media releasesInformation on how supplements are regulated in Australia
-
Media releasesImprovements to Consumer Medicine Information
-
Media releasesImportant information about the dangers of using thermography for breast cancer detection